Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma

The protein kinase V-Raf murine sarcoma viral oncogene homolog B (BRAF) is an oncogenic driver and therapeutic target in melanoma. Inhibitors of BRAF (BRAFi) have shown high response rates and extended survival in melanoma patients bearing tumors that express BRAF Val600 mutations, but a vast majori...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Med
Auteurs principaux: Shen, Che-Hung, Kim, Sun Hye, Trousil, Sebastian, Frederick, Dennie T., Piris, Adriano, Yuan, Ping, Cai, Li, Gu, Lei, Li, Man, Lee, Jung Hyun, Mitra, Devarati, Fisher, David E., Sullivan, Ryan J., Flaherty, Keith T., Zheng, Bin
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014622/
https://ncbi.nlm.nih.gov/pubmed/27500726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4155
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires